Julien Edeline
Centre Eugène Marquis · CLCC UNICANCER EUGENE MARQUIS · Centre de Lutte contre le Cancer Eugène Marquis
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Julien Edeline as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:55 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07745296 · Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract CancerUNICANCER · not yet recruiting · Biliary Tract Cancer (BTC) · principal investigator
- Ph2/Ph3NCT06904170 · Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular CarcinomaUNICANCER · recruiting · Hepatocellular Carcinoma · principal investigator
- Ph2NCT06529718 · Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer PatientsUNICANCER · recruiting · Biliary Tract Cancer · principal investigator
- Ph2NCT05622071 · Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver FunctionsUNICANCER · completed · Hepatocellular Carcinoma by BCLC Stage · principal investigator
- Ph3NCT05615818 · Personalized Medicine for Advanced Biliary Cancer PatientsUNICANCER · recruiting · Biliary Tract Neoplasms · principal investigator
- Ph2NCT05265208 · Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver CancerCenter Eugene Marquis · recruiting · Resectable Intrahepatic Cholangiocarcinoma · principal investigator
- N/ANCT02921646 · Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas CancerCenter Eugene Marquis · terminated · Metastatic Pancreatic Cancer · principal investigator
- N/ANCT02003339 · Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With YttriumCenter Eugene Marquis · completed · Hepatocellular Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:55 UTC. The ranking covers the 200 most relevant of 32 PubMed records, and a shared surname and initials can bring in a namesake. All 32 on PubMed
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.Lancet Oncol · 20182,109 citationsRCR 76.0
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial.J Clin Oncol · 20201,522 citationsRCR 68.5
- 1,063 citationsRCR 99.5
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.Lancet Oncol · 20221,010 citationsRCR 72.7
- Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.Lancet Gastroenterol Hepatol · 2021529 citationsRCR 39.9
- Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.J Clin Oncol · 2019442 citationsRCR 19.8
- Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.Lancet Oncol · 2023433 citationsRCR 38.6
- Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.JAMA Oncol · 2020238 citationsRCR 12.8
- Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.Eur J Cancer · 2022118 citationsRCR 8.2
- Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study.J Clin Oncol · 2022117 citationsRCR 7.5